Nezam H. Afdhal, Chief Medical Officer at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 1,900 shares at $11.43 ($22K) on 2016-08-15, disclosed to the SEC on 2016-08-16.
Open-market purchase of $22k SBPH by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.43 | 1,800 | $21K | 94.7% |
| 2 | $11.49 | 100 | $1K | 5.3% |
| Total | $11.43 avg | 1,900 | $22K | 100% |
| Filing → |
| SBPH | BUY | 2016-08-16 | $57K | — | Filing → |
| SBPH | BUY | 2016-08-15 | $29K | — | Filing → |